Abstract

The pharmacological characterisation and topographical distribution of [ 3H]-(S)-zacopride recognition sites in the forebrain of the rat was studied using homogenate and autoradiographic radioligand binding techniques. [ 3H]-(S)-Zacopride labelled a single, saturable, specific binding site (defined by 10.0 μM granisetron) in homogenates prepared from the entorhinal cortex of the rat (p K D = 9.5 l ±0.08; B max = 104 ± 7 fmolmg −1 protein; mean ± SEM, n = 8). Pharmacological characterisatio of the recognition site, within the entorhinal cortex, suggested that [ 3H]-(S)-zacopride selectively labelled the recognition site of the 5-HT 3 receptor. Specific binding of [ 3H]-(S)-zacopride (defined by 1.0 μM granisetron) was differentially distributed throughout the forebrain of the rat; highest densities were located within sub-nuclei of the amygdala (cortical amygdaloid nucleus, amygdalohippocampal area, posterior medial cortical amygdaloid nucleus, posterior lateral amygdaloid nucleus), cortical areas (primary olfactory cortex, entorhinal cortex) and hippocampus. Non-specific binding was distributed homogeneously, although lower in myelinated structures. It is concluded that [ 3H]-(S)-zacopride selectively labels 5-HT 3 receptor recognition sites within the forebrain of the rat; the topographical distribution of these sites, within the limbic nuclei, is consistent with the behavioural actions in animal models of the selective 5-HT 3 receptor antagonists.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.